Financial Comparison
Boston Scientific Corporation vs Stryker Corp
Click a ticker to view the full analysis.
In short
Boston Scientific Corporation is the more profitable of the two, keeping 14.4% of revenue as net profit against 12.9% for Stryker Corp. Stryker Corp trades at the higher trailing P/E (28.7× vs 17.0× for Boston Scientific Corporation), so investors pay more for each dollar of its earnings. Fisclear flags 1 medium- or high-severity risk for Boston Scientific Corporation and 1 for Stryker Corp.
Based on filings for periods ending 30 Jun 2026 (BSX) and 30 Jun 2026 (SYK) · Updated
FisclearScore Comparison
FisclearScore is a quantitative model. BSX shown solid · SYK shown dashed. Not financial advice.
| Metric | BSX | SYK |
|---|---|---|
| Price | $42.04 | $276.97 |
| Market Cap | $60.9B | $106.2B |
| P/E (TTM) | 17.0x | 28.7x |
| P/B | 2.4x | 4.4x |
| Beta | 0.57 | 0.78 |
| Div Yield | 0.00% | 1.25% |
| Revenue (TTM) | $20.1B | $25.1B |
| Net Income | $2.9B | $3.2B |
| Gross Margin | 69.0% | 64.0% |
| Risk Flags | 1 flag | 1 flag |
Related comparisons
Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.